New-onset Afib is the most common complication after cardiac surgery, and the BoxX-NoAF clincial trial is exploring a proactive approach.
Discover more about the trial here: <a href="https://t.co/XtJ50uS8yc" target="_blank">https://t.co/XtJ50uS8yc</a>
